SASS 2 : Self Assembled Skin Substitute for the Autologous Treatment of Severe Burn Wounds in Acute Stage of Burn Trauma (NCT02350205)
SASS 2 : Self Assembled Skin Substitute for the Autologous Treatment of Severe Burn Wounds in Acute Stage of Burn Trauma.
🩺 Plain-English Summary (8th-Grade Level)
This clinical trial is designed to assess the safety, effectiveness and benefits of Self Assembled Skin Substitute SASS grafts as a permanent skin replacement for the treatment of full-thickness burn wounds that require permanent coverage where the availability of donor sites is limited.
Who can join: Review the eligibility criteria below.
Location: Foothill Medcial Centre — Calgary, Alberta
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (8 Sites)
- Foothill Medcial Centre — Calgary, Alberta
- Mackenzie Health Science's Centre — Edmonton, Alberta
- Vancouver General Hospital — Vancouver, British Columbia
- BC Children's Hospital Plastic Surgery Clinic — Vancouver, British Columbia
- Winnipeg Health Science Center — Winnipeg, Manitoba
- Hospital for Sick Children (Sickkids) — Toronto, Ontario
- Hôpital Sainte Justine — Montreal, Quebec
- CHU de Québec - Unité des grands brûlés — Québec, Quebec
📞 Contact the Study Coordinator
Phone: (418) 525-4444
Email: veronique.moulin@fmed.ulaval.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Burns
- Assessment of Safety and Effectiveness of NovoSorb® BTM in Severe Burns — Phoenix, Arizona
- Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection — Oklahoma City, Oklahoma
- The Effects of Metformin on Morbidity and Mortality in Elderly Patients — Hamilton, Ontario
- A Phase I, Single-blind, Randomized Study of the Safety and Efficacy of Cellularized Integra® Using Autologous Burn-derived Stem Cells — Hamilton, Ontario
- A Pilot Trial of Disposable Nitrous Oxide Canisters in Providing Pain Control During Burn Dressing Changes — Winnipeg, Manitoba
- 4-Aminopyridine to Treat Skin Burns — Tucson, Arizona
Explore by condition: All Burns clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.